LaFleur & Godfrey LLC cut its position in shares of Perrigo Company (NYSE:PRGO) by 2.7% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 41,901 shares of the company’s stock after selling 1,145 shares during the period. LaFleur & Godfrey LLC’s holdings in Perrigo were worth $3,164,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the stock. Moon Capital Management LLC boosted its position in shares of Perrigo by 0.6% in the first quarter. Moon Capital Management LLC now owns 43,265 shares of the company’s stock worth $2,872,000 after buying an additional 240 shares in the last quarter. Credit Suisse AG boosted its position in shares of Perrigo by 13.8% in the first quarter. Credit Suisse AG now owns 241,688 shares of the company’s stock worth $16,046,000 after buying an additional 29,375 shares in the last quarter. State of New Jersey Common Pension Fund D acquired a new position in shares of Perrigo during the first quarter worth about $29,876,000. Amalgamated Bank boosted its position in shares of Perrigo by 6.0% in the first quarter. Amalgamated Bank now owns 9,759 shares of the company’s stock worth $648,000 after buying an additional 555 shares in the last quarter. Finally, Chevy Chase Trust Holdings Inc. boosted its position in shares of Perrigo by 3.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 123,597 shares of the company’s stock worth $8,205,000 after buying an additional 3,792 shares in the last quarter. Institutional investors own 76.38% of the company’s stock.

Shares of Perrigo Company (NYSE PRGO) opened at 78.49 on Friday. The company’s 50 day moving average is $73.59 and its 200-day moving average is $73.05. Perrigo Company has a 12 month low of $63.68 and a 12 month high of $99.14. The firm’s market cap is $11.25 billion.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Thursday, August 10th. The company reported $1.22 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.28. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.18 billion. Perrigo had a positive return on equity of 11.37% and a negative net margin of 51.04%. Perrigo’s revenue for the quarter was down 7.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.93 earnings per share. Equities research analysts predict that Perrigo Company will post $4.32 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 25th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date is Wednesday, August 23rd. Perrigo’s dividend payout ratio (DPR) is presently -3.51%.

WARNING: This report was reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.dailypolitical.com/2017/08/12/lafleur-godfrey-llc-sells-1145-shares-of-perrigo-company-nyseprgo.html.

A number of equities analysts have recently issued reports on PRGO shares. Wells Fargo & Company restated a “market perform” rating and issued a $67.00 price objective on shares of Perrigo in a research note on Friday, April 14th. Deutsche Bank AG dropped their price objective on shares of Perrigo from $87.00 to $86.00 and set a “buy” rating for the company in a research note on Wednesday, April 19th. B. Riley restated a “neutral” rating and issued a $67.00 price objective on shares of Perrigo in a research note on Saturday, April 22nd. Jefferies Group LLC restated a “hold” rating and issued a $71.00 price objective on shares of Perrigo in a research note on Wednesday, May 24th. Finally, Canaccord Genuity set a $86.00 price objective on shares of Perrigo and gave the company a “buy” rating in a research note on Monday, May 22nd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $85.31.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.